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Objective: The purpose of the study was to carry out a candidate gene analysis in
families with familial thoracic aortic aneurysms and dissections.
Methods: The study material consisted of 11 Finnish families (with 115 members
genotyped) who underwent echocardiographic examination for measurement of the
aortic root diameter. Selected candidate genes included the loci for Marfan and
Ehlers-Danlos syndromes, the genes of matrix metalloproteinases 3 and 9 and tissue
inhibitor of metalloproteinase 2 as well two loci on the chromosomes 5q13-14 and
11q23.2-q24, previously found to be linked to the disease.
Results: The chromosomal locus 5q13-14 was linked to the disease risk (nonpara-
metric linkage score 3.0, P  .005) confirming the previous linkage. Other candi-
date genes and loci were excluded as major loci in these families.
Conclusions: The identification of the gene at chromosomal location 5q13-14
causing the development of such diseases would give us important knowledge on
the pathogenesis of the disease and enable the identification of subjects at risk. This
in turn would lead to appropriate treatment before the occurrence of fatal compli-
cations and, likely, to the development of new treatment methods.
Aortic aneurysm and dissections (including both abdominal andthoracic aorta) are responsible for about 1%-2% of the totalmortality in affluent societies, aneurysm rupture being the firstand often fatal manifestation of these diseases. The most impor-tant risk factors associated with the development of thoracic aorticaneurysms and dissections are chronic obstructive pulmonary
disease, hypertension, and aging. At least one fifth of the aneurysms of the thoracic
aorta other than those in patients with Marfan syndrome are due to genetic factors.1
The genetic risk has been illustrated in a family study, in which the risk of a brother
of a patient with thoracic aortic aneurysm of developing an aneurysm was 11 times
higher than the risk in the general population, whereas for sisters it was two times
higher.2 In addition, familial cases are younger and their aneurysms grow faster than
the sporadic ones.1
Although an obvious genetic risk on a proportion of patients with thoracic aortic
aneurysms and dissections has been clearly defined, no major genetic locus for
familial thoracic aortic aneurysms and dissections (FTAAD) has been found at the
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population level so far. The inheritance pattern of FTAAD
has been suggested to be autosomal dominant but complex
with reduced and age-dependent penetrance.3 Other inheri-
tance patterns have, however, also been proposed suggest-
ing genetic heterogeneity.1,2 Although patients with Marfan
syndrome and Ehlers-Danlos syndrome type IV have an
increased risk for the development of aortic aneurysm and
dissections, only 10% of patient with thoracic aortic an-
eurysm have Marfan syndrome and even fewer have Ehlers-
Danlos syndrome.1 The loci for such rare syndromes have
been mapped. The major locus for Marfan syndrome is
located on the chromosome 15q21.1 (fibrillin 1, FBN1) and
the second potential, still unconfirmed, locus on the chro-
mosome 3p24-p25, whereas Ehlers-Danlos syndrome type
IV is due to mutations of the type III collagen gene
(COL3A1) on the chromosomal location 2q31.4-7 These loci
have also been found in some families to be linked to the
development of aortic aneurysms without any other mani-
festations typical of such syndromes.6,7 Recently, two ge-
nome-wide linkage studies have found two novel loci for
FTAAD in the chromosomal locations 5q13-14 and
11q23.2-q24.8,9 Among patients with abdominal aortic an-
eurysms, an association has been found between the risk of
developing the disease and either genetic polymorphisms or
the level of gene expression for matrix metalloproteinases 3
and 9 (MMP3 and MMP9) and tissue inhibitor of metallo-
proteinase 2 (TIMP2).10-12
The first clinical manifestation of FTAAD is often aortic
rupture, which is frequently fatal.13 The identification of
major loci and therefore the subjects at risk would make the
treatment possible before such a severe complication oc-
curs. The genetic homogeneity and small number of original
founders make the Finnish population ideal for the disease
gene identification by decreasing locus and allelic hetero-
geneity, not only in monogenic disorders, but also in more
heterogeneous multifactorial disorders, like FTAAD.14 The
aim of the current study was to test whether any of the
candidate loci, including loci for 5q13-14, 11q23.2-q24 and
FBN1, and the genes of COL3A1, MMP3, MMP9, and
TIMP2, are linked to the risk of developing ascending aortic
aneurysms or dissections (type A) in 11 Finnish families
taken from a homogenous population.
Methods
Subjects
Families with members having had thoracic aortic aneurysm and
dissections were collected based on probands treated at the Uni-
versity Hospitals of Oulu and Tampere. Families with at least 2
members with thoracic aortic aneurysms or dissections were col-
lected. The total number of families included in the present study
was 11 (with 115 subjects genotyped), 7 from Oulu and 4 from
Tampere. The pedigrees are shown in Figure 1. A blood sample for
DNA extraction and lipid measurement was obtained from every
study subject. A physical examination was carried out excluding
classic Marfan syndrome in the families. The information about
medication, past medical history, alcohol consumption (recorded
as grams of alcohol consumed in a week), smoking (recorded as
nonsmoker or current smoker, pack-years of smoking, and the
number of cigarettes smoked currently), and leisure activity were
elicited with a questionnaire. Death certificates were provided by
Statistics Finland and were used, if based on autopsy, to confirm
the phenotypes of the deceased family members. For most of the
unaffected family members, transthoracic echocardiography with
aortic root measurements was done to confirm the phenotype. The
study was approved by the Ethical Committees of the Universities
of Oulu and Tampere, and all subjects gave written informed
consent.
Echocardiography
Transthoracic echocardiography was performed with the study
subject in the left lateral recumbent position using at the University
of Tampere an Acuson 128/XP10 (Acuson, Mountain View, Calif)
and at the University of Oulu a Hewlett-Packard Sonos 5500
echocardiographic system (Hewlett-Packard, Andover, Mass).
Transthoracic scanning was performed either with a 2.5-MHz or
3.5-MHz probe from the parasternal, apical, and subcostal win-
dows. The echocardiographic examinations were recorded on con-
tinuous videotape for off-line analysis system. Cardiac chamber
diameters and wall thickness were measured from transthoracic 50
mm/s M-mode recordings according to the recommendations of
American Society of Echocardiography.15 The mean of at least 3
consecutive cardiac cycles was used. Normal values for aortic root
were taken from the Framingham Heart Study material, and taking
into account sex, height, and age of the subject.16
Genotyping of Microsatellite Markers
MTS1 and MTS2 microsatellite markers were selected for the
major Marfan syndrome locus (FBN1), and the sequences of the
primers were taken as published.17 The following microsatellite
markers were selected and their sequences were taken from the
Genome Database (www.gdb.org): D11S1924 and D11S1302 for
the MMP3 gene, CLG4B and D20S888 for the MMP9 gene,
D17S836 and D17S784 for the TIMP2 gene, D2S117 and
COL3A18 for the COL3A1 gene. The selection of the markers was
based on the distance 4 cM from the candidate locus and on the
high level of heterozygosity. D5S253, D5S2029, D5S626 for the
chromosomal locus 5q13-14 and D11S1341, D11S924 and
D11S528 for the chromosomal locus 11q23.2-24 were most sig-
nificantly linked markers previously8,9 and, therefore, selected.
After positive results were found in chromosome 5, more markers
were genotyped in that area, namely D5S2089, D5S1464, D5S641,
D5S806, D5S1725, and D5S107.
Polymerase chain reactions (PCR) were carried out utilizing the
BioMek1000 automatic pipettor (Beckman Instruments, Fullerton,
Calif) in a total volume of 7.5 L containing 30 ng of genomic
DNA, 200 M of each dNTP, 1.3-2.3 pmol of each primer, 0.3
units of AmpliGold polymerase (Applied Biosystems, Foster City,
Calif) and 1.5 mM MgCl2 in the buffer recommended by the
manufacturer. PCR was carried out with a pre-PCR heat step of 12
minutes at 95°C, followed by 10 cycles of 30 seconds at 94°C, 30
seconds at 55°C-64°C, and 45 seconds at 72°C and finally by 30
cycles of 30 seconds at 89°C, 30 seconds at 55°C-64°C and 45
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Figure 1. The pedigrees of the FTAAD families participating in the study. The study subjects genotyped are
numbered with Arabic numbers, whereas family members not genotyped are numbered with Roman numbers.
Three subjects with abdominal aortic aneurysms (subject V in the family 5, subject X in the family 7, and subject
VIII in the family 8) were coded to have unknown phenotype in the analysis, but are marked as affected in the
figure.
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seconds at 72°C. PCR was completed with 10 minutes at 72°C.
The PCR products were electrophoresed with an ABI 377 auto-
matic sequencer (Applied Biosystems). The size of the alleles was
determined based on the Genescan-500 size standard (Applied
Biosystems), which was included in every sample, and done by
utilizing the Genescan and Genotyper programs (Versions 3.1 and
2.0, respectively; Applied Biosystems). The results of genotyping
were confirmed by two independent observers.
Statistical Analysis
The phenotypes of patients younger than 26 years (the age of the
youngest patients with aneurysm) were selected to be unknown to
reduce the possibility of incorrect phenotyping due to possible
age-dependent penetrance at the dominant model of parametric
linkage analysis. Subjects with an aortic root 3 mm over the
upper normal limit or operated for aortic aneurysm or dissection
were classified as affected. Those with an aortic root diameter
smaller than the upper limit were classified as unaffected and the
others as with unknown phenotype. Three subjects with abdominal
aortic aneurysms (the subject V in the family 5, the subject X in the
family 7 and the subject VIII in the family 8) were coded to have
unknown phenotype. The parametric and nonparametric multipoint
linkage analysis was carried out with GeneHunter2 program18 in
the computers of CSC-Scientific Computing Ltd (Espoo, Finland).
The test for genetic heterogeneity, ie, that different loci are linked
to the FTAAD risk in different families, was carried out with the
HOMOG program. The marker allele frequencies were estimated
based on all founders and unrelated family members (n 20). The
TABLE 1. The manifestation of FTAAD in study subjects
Family Subject no. Manifestation Age at onset Sex
1 76 Dilatation of ascending aorta (37 mm;  4 mm) 56 F
81 Operated for aortic dissection (A-type) 47 M
2 2 Dilatation of aortic root (51 mm;  14 mm) 51 M
49 Dilatation of aortic root (35 mm;  4 mm) 40 F
1 Death due to aortic dissection (A-type) 62 M
3 16 Operated for aortic dissection (A-type) 46 M
21 Dilatation of aortic root (42 mm;  5 mm) 46 M
4 3 Dilatation of aortic root (41 mm;  4 mm) 38 M
18 Dilatation of ascending aorta (60 mm), operated 57 F
30 Operated for aortic dissection (A-type) 28 M
III Death due to aortic dissection (A-type) 53 M
5 26 Operated for aortic dissection (A-type) 26 M
47 Dilatation of aortic root (36 mm;  4 mm) 29 F
IV Death due to aortic dissection (A-type) 65 M
6 83 Dilatation of ascending aorta (42 mm;  6 mm) 87 F
84 Dilatation of aortic root (48 mm;  16 mm) 40 F
90 Dilatation of aortic root (44 mm;  4 mm) 74 M
IV Death due to aortic dissection (A-type) 62 M
7 82 Operated for dilatation of ascending aorta 64 M
106 Dilatation of aortic root (39 mm;  4 mm) 34 M
8 27 Operated for aneurysm of ascending aorta (65 mm) 56 F
56 Dilatation of ascending aorta (40 mm;  8 mm) 47 F
61 Dilatation of ascending aorta (43 mm;  6 mm) 54 M
9 IV Death due to aortic dissection (A-type) 80 M
VII Death due to aortic dissection (A-type) 52 M
VIII Death due to aortic dissection (A-type) 72 M
10 102 Dilatation of aortic root (38 mm;  5 mm) 46 F
104 Operated for annuloaortic ectasia 50 F
105 Dilatation of aortic root (40 mm;  9 mm) 26 F
108 Dilatation of aortic root (36 mm;  4 mm) 47 F
109 Dilatation of aortic root (45 mm;  7 mm) 61 M
110 Dilatation of aortic root (44 mm;  6 mm) 51 M
114 Dilatation of aortic root (50 mm;  15 mm) 29 M
115 Dilatation of aortic root (47 mm;  10 mm) 43 M
IV Death due to aortic dissection (A-type) 53 F
11 1 Death due to aortic dissection (A-type) 45 M
14 Dilatation of ascending aorta (40 mm;  4 mm) 40 M
15 Operated due to aneurysm of ascending aorta (52 mm) 45 F
45 Operated for ascending aortic aneurysm 29 M
F, Female; M, male. The numbers of subjects and families refer to Figure 1. Figures in parenthesis show the aortic root diameter and how much it is over
the upper normal limit. The upper normal limits for aortic root taking into account the age, height, and sex of the study subjects are taken from Vasan et
al.16
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distances between the microsatellite markers and candidate genes
were taken from GeneMap99 (www.ncbi.nlm.nih.gov/genemap)
or from the Ensembl Genome Server (www.ensembl.org).
The NPL (nonparametric linkage) score was taken as a primary
result since no assumptions of inheritance patterns (of the fre-
quency of disease-causing allele in the population and of pen-
etrances, ie, the probability of being affected, of different geno-
types) were needed as in parametric linkage analysis. The NPL
statistics measures allele sharing among affected individuals
within a pedigree using all available marker data on chromosome
at the same analysis and estimates the statistical significance for
the detected linkage between marker loci and disease locus at the
sample. For parametric linkage analysis, the selection of best
models was based on the simulations made with the data and the
dominant model was chosen (with the penetrances of the wild type,
heterozygous and homozygous genotypes of 0.01, 0.90, and 0.90).
In addition, the model with age-dependent penetrances (with the
penetrances of 0.001, 0.10, and 0.10 for subjects younger than 30
years; 0.01, 0.30, and 0.30 for subjects between 30 and 40 years,
0.01, 0.70, and 0.70 for subjects 40-60 years; and 0.01, 0.90, and
0.90 for subjects over 60 years, similar to that published earlier8)
was used in the analysis. The frequency of the disease allele was
assumed to be 0.1%. However, based on simulations, the analysis
was not sensitive for the changes in the frequency of the disease
allele. The criteria for significances were taken as published, in
which a nominal P value of 0.01 was required for the confirmation
of linkage.19
Results
Among genotyped subjects over 26 years old, there were 38
unaffected subjects (all of them having had their aortic root
measured by ultrasound) and 31 affected subjects (the man-
ifestations of FTAAD for every affected study subjects and
their deceased family members are shown on Table 1). The
phenotypes of 46 subjects remained unknown. In 17 sub-
jects the aortic root was not measured, whereas 19 subjects
had the diameter of their aortic root close to upper normal
limit. There were 10 subjects younger than 26 years (the age
of youngest patients), therefore, having their phenotype
coded as unknown. In overall, the aortic root was measured
for 85 subjects and ranged between 22 and 65 mm.
The characteristics of the affected and unaffected study
subjects excluding subjects with unknown phenotype are
shown on Table 2. Among unaffected subjects, the aortic
root was larger in men than in women (mean of 33.0 vs.
28.5 mm, P  .001). Coronary heart disease was uncom-
mon in the study subjects (Table 2) and there was no
difference in the history of coronary heart disease between
unaffected and affected subjects. However, the affected
subjects had more frequently hypertension than unaffected
subjects (55% vs. 21%, P  .008). No significant differ-
ences in the lipid values or in body mass index were
detected between affected and unaffected subjects. There
were 13 women and 18 men in the affected subjects group.
The best multipoint nonparametric linkage (NPL) and
logarithm of odds (LOD) scores for the genotyped loci at
the initial screen are shown on Table 3. The genotyped loci,
except the chromosomal locus 5q13-14, were excluded as a
major locus for FTAAD. For chromosomal locus 5q13-14
more markers were genotyped yielding the best NPL score
of 3.0 (P  .005) at map position  20 cM (Figure 2) with
the best parametric multipoint LOD scores of 2.01 (domi-
nant model, Figure 2) and 1.10 (age-dependent penetrance
model). Table 4 shows the best multipoint NPL scores and
LOD scores for single families at the position with the
highest overall scores showing that most but not all families
were linked to the locus. The most significant single point
NPL score, 2.48 (P  .01), and the best parametric LOD
score with dominant model, 3.16, were for the marker
D5S1464. There was, however, no evidence for the locus
heterogeneity between the families tested by HOMOG pro-
TABLE 2. Characteristics of study subjects
Men Women
Affected Unaffected Affected Unaffected
No. of subjects 18 20 13 18
Age 49.6 [34-83] 43.1 [27-76] 50.4 [26-87] 53.3 [31-76]
Total cholesterol (mmol/L) 5.86 (1.16) 5.29 (1.17) 5.45 (0.74) 5.37 (0.88)
HDL cholesterol (mmol/L) 1.20 (0.31) 1.26 (0.32) 1.58 (0.45) 1.73 (0.42)
LDL cholesterol (mmol/L) 3.40 (1.06) 3.28 (1.11) 3.18 (0.50) 3.06 (0.93)
Triglycerides (mmol/L) 3.78 (7.34) 1.64 (0.98) 1.49 (0.69) 1.20 (0.50)
Body mass index (kg/m2) 26.9 (3.3) 26.5 (4.2) 23.0 (3.0) 25.0 (4.9)
Aortic root diameter (mm) n 10 n 20 n 10 n 17
43.6 [39-50] 33.5 [27-38]† 42.1 [35-65] 29.4 [24-33]*
Hypertension 11 (61%) 5 (25%) 6 (46%) 3 (17%)
Coronary heart disease 1 (6%) 1 (5%) 0 2 (11%)
Figures are shown as number of subjects (percentages) or as means (standard deviations) or as means [ranges]. HDL, High-density lipoproteins. LDL,
low-density lipoproteins. Subjects with unknown phenotype (n  46) are excluded from the table.
*P  .01.
†P  .001.
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gram with the marker D5S1464, probably due to low num-
ber of the families. The haplotypes of markers at chromo-
somal location 5q13-14 for two families with the highest
NPL scores (families 4 and 7) are shown on Figure 3.
Discussion
The risk of developing aneurysms and dissections of tho-
racic aorta is partly inherited.1 However, previous studies
reported controversial results of the inheritance pattern and
the major loci of FTAAD suggesting heterogeneous genetic
background.1-3,6-9 The Finnish population, with small num-
bers of original founders and minimal immigration during
many centuries, should be powerful for the disease gene
identification.14 The aim of the current study was to search
FTAAD locus in Finnish families using linkage analysis of
candidate genes and loci and, by this approach, we were
able to confirm the previous linkage of FTAAD to 5q13-
14.8 The multipoint NPL score 3.0 (P  .005) meets the
requirement for the confirmed linkage proposed by Lander
and Kruglyak.19
The establishment of 5q13-14 as a locus for FTAAD
makes the testing of disease risk possible in those families
with FTAAD risk linked to the locus. The fact that other loci
have also been found to be linked to the FTAAD risk in
single families6,7,9 makes the estimation of the disease risk
in individuals somewhat difficult and at least, population-
based. Most of our families (Table 4), however, were linked
to the locus pointing out its importance in the Finnish
population. Because the same locus was originally found to
be linked to the risk of FTAAD in around half of the
Caucasian families collected at least partly from the USA,8
the importance of the locus should not be unique for Finnish
population. Anyway, not all families, even in our homoge-
nous sample, were linked to the 5q13-14 locus showing the
heterogeneous genetic background of FTAAD.
There were a few old subjects carrying the disease allele
without aortic root dilatation. The observed reduced pen-
etrance of FTAAD genes has been supported by earlier
studies.3 FTAAD in the sample seemed to manifest from
aortic root dilatation to fatal aortic dissection (Table 1). It is
possible that the final manifestations of FTAAD, even in
families in which the disease risk is linked to a major locus,
are affected also by other genes or environmental factors
(such as the presence of hypertension), not only by a single
predisposing locus (like 5q13-14). Aneurysms and dissec-
tions of abdominal aorta are strongly associated with ath-
erosclerosis,20 whereas no association between FTAAD and
coronary heart disease was detected in our study subjects,
thus, suggesting that the genetic defect leading to the de-
velopment of FTAAD is not related to development of
TABLE 3. The highest multipoint NPL and LOD scores of
markers close to selected candidate loci for FTAAD
Candidate locus NPL score
Parametric LOD score
Dominant
Age-
dependent
MMP3 0.34 (P .34) 2.74 1.35
MMP9 1.40 (P .09) 2.86 1.45
TIMP2 0.48 (P .67) 3.01 2.78
COL3A1 0.06 (P .50) 6.63 5.01
FBN1 0.16 (P .41) 6.51 6.08
5q13-14 2.67 (P .009) 1.45 1.25
11q23.2-q24 0.22 (P .40) 4.03 1.17
The highest multipoint NPL score and LOD scores at the interval between
genotyped markers of each candidate locus are shown.
Figure 2. Multipoint NPL scores and LOD scores of dominant
model for the chromosomal locus 5q13-14.
TABLE 4. The highest multipoint NPL scores and LOD
scores for single families at the locus 5q13-14
Family
no. NPL score
Parametric LOD score
Dominant
Age-
dependent
1 0.38 0.15 0.14
2 1.34 0.66 0.66
3 1.41 0.25 0.25
4 2.10 1.13 1.13
5 0.18 1.00 1.02
6 0.74 0.84 0.13
7 2.65 0.71 0.46
8 0.82 0.07 0.34
9 0.03 0.13 0.13
10 0.15 0.95 0.95
11 1.72 0.58 0.37
Total 3.03 2.01 1.10
The highest total NPL score and LOD scores with both models were at the
position 20 cM (Figure 2) and the scores for single families are shown at
this position.
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Figure 3. The haplotypes of markers at chromosomal location 5q13-14 for families 4 and 7 with the highest NPL
scores. The subject X in family 7 has abdominal aortic aneurysm (AAA).
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atherosclerosis. The affected subjects had more frequently
drug-treated hypertension than unaffected subjects. How-
ever, such a difference might be overestimated, because
antihypertensive treatment was easily started on at the time
of diagnosis of aortic aneurysm or dissection.
The reliable and strict phenotyping of the study subjects
enabled us to confirm the previous linkage in a sample
consisting of only 11 families. Only those over 26 years of
age and, by ultrasound measurements, determining their
aortic root size to be smaller than the upper normal limit
were considered as unaffected. The normal values were
derived from the large Framingham study material, which
took into account sex, age, and height.16 In addition to the
patients operated on for aortic dilatation or aneurysms, those
having their aortic root at least 3 mm over upper normal
limit were considered as affected. The strict limit of 3 mm
was taken to avoid incorrect phenotypes due to possible
errors of measurements.
The next step will be to identify the disease gene and
mutations in the gene enabling the development of new
effective therapies preventing the development and progres-
sion of thoracic aortic aneurysms and dissections. Before
such strategies would be available, identification of patients
at risk for development of FTAAD would permit an ade-
quate surveillance of such subjects and/or elective surgical
repair before the occurrence of severe and often fatal com-
plications.
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